Larimar Therapeutics, Inc. (LRMR)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

14 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012
Revenue$0$0$0$0$0$0$0$0
Research & development$154.2M$73.3M$27.7M$24.3M$38.4M$31.4M$20.8M$47.9M$40.8M$39.9M$54.6M$27.4M$9.6M$11.5M
Operating expenses$172.5M$90.9M$41.8M$36.5M$50.5M$42.8M$23.2M$61.1M$53.0M$58.2M$73.8M$35.5M$13.8M$13.8M
Operating income−$172.5M−$90.9M−$41.8M−$36.5M−$50.5M−$42.8M−$23.2M−$61.1M−$53.0M−$58.2M−$73.8M−$35.5M−$13.8M−$13.8M
Net income−$165.7M−$80.6M−$36.9M−$35.4M−$50.6M−$42.5M−$23.1M−$61.4M−$52.0M−$57.9M−$74.3M−$36.5M−$14.0M−$13.9M
Basic EPSper diluted share-$1.32-$0.84-$1.37-$2.95-$3.57-$3.80-$1.90-$1.90-$2.12-$2.78-$3.00-$19.53-$19.65
Diluted EPSper diluted share-$1.32-$0.84-$1.37-$2.95-$3.57-$3.80-$1.90-$1.90-$2.12-$2.78-$3.00-$19.53-$19.65

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys10$55.55M disclosed value
Sells (SEC code S)0$0.00 disclosed value
10 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Feb 27, 2026Form 4Deerfield Mgmt HIF, L.P. +9Director,TenPercentOwner,OtherBuyCommon Stock · indirect2.00M$5.00$10.00M6.21M
Feb 27, 2026Form 4Deerfield Mgmt HIF, L.P. +9Director,TenPercentOwner,OtherBuyCommon Stock · indirect832.0K$5.00$4.16M8.15M
Feb 27, 2026Form 4Deerfield Mgmt HIF, L.P. +9Director,TenPercentOwner,OtherBuyCommon Stock · indirect1.08M$5.00$5.42M10.62M
Feb 27, 2026Form 4Deerfield Mgmt HIF, L.P. +9Director,TenPercentOwner,OtherBuyCommon Stock · indirect1.08M$5.00$5.42M10.62M
Feb 27, 2026Form 4Hamilton Thomas EdwardDirectorBuyCommon Stock100.0K$5.00$500.0K664.8K